Loading RPRX…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("RPRX","financials")Full statements spill as a table. For one cell: =jivedata("RPRX","Revenue") or =jivedata("RPRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
RPRX • CIK 0001802768
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $2,354,554 | $2,263,576 | $2,378,193 | $2,535,998 |
| Operating Income (Loss) | $1,492,150 | $1,292,444 | $1,559,518 | $1,511,694 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $1,700,088 | $1,330,813 | $1,324,192 | $1,349,865 |
| Income Tax Expense (Benefit) | $0 | $0 | $0 | $0 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $565,254 | $471,830 | $553,245 | $534,871 |
| Net Income (Loss) Attributable to Parent | $1,134,834 | $858,983 | $770,947 | $814,994 |
| Provision for Other Credit Losses | $560,656 | $732,461 | $-295,838 | $105,972 |
| Research and Development Expense | $52,000 | $2,000 | $452,000 | $238,641 |
| General and Administrative Expense | $249,748 | $236,671 | $573,481 | $604,383 |
| Costs and Expenses | $862,404 | $971,132 | $818,675 | $1,024,304 |
| Income (Loss) from Equity Method Investments | $28,882 | $29,611 | $29,089 | $45,788 |
| InterestExpenseNonoperating | — | $225,512 | $307,664 | $361,074 |
| Gain (Loss) on Derivative Instruments, Net, Pretax | $-2,290 | $-6,000 | $0 | $0 |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | $87,139 | $39,549 | $-21,852 | $103,569 |
| Debt Securities, Available-for-sale, Unrealized Gain (Loss) | $230,840 | $154,906 | $45,859 | $35,000 |
| Interest Income, Other | — | $47,343 | $33,591 | $25,330 |
| Other Nonoperating Income (Expense) | $-21,737 | $-1,528 | $-14,349 | $-13,442 |
| Nonoperating Income (Expense) | $207,938 | $38,369 | $-235,326 | $-161,829 |
| Weighted Average Number of Shares Outstanding, Basic | 447,601,000 | 448,185,000 | 429,801,000 | 441,287,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 602,900,000 | 594,108,000 | 564,455,000 | 551,650,000 |
| Share-based Payment Arrangement, Expense | — | — | $290,890 | $428,791 |
| Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities | $392,726 | $276,893 | — | $352,112 |
| Net Income (Loss) Available to Common Stockholders, Diluted | $1,527,560 | $1,135,876 | $1,005,522 | $1,048,712 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 7,000 | 12,000 | 14,000 | 148,000 |
| Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares | 155,292,000 | 145,911,000 | 270,000 | 170,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Financing Receivable, after Allowance for Credit Loss, Noncurrent | $14,088,655 | $15,127,158 | $16,208,482 | $16,192,717 |
| EquitySecuritiesFVNINoncurrent | $199,487 | $186,960 | $171,312 | $241,918 |
| Debt Securities, Available-for-sale, Noncurrent | $437,100 | $693,500 | $419,000 | $372,100 |
| Equity Method Investments | $375,894 | $379,424 | $289,968 | $261,973 |
| Goodwill | — | — | $924,634 | $923,535 |
| Other Assets, Noncurrent | $6,522 | $33,534 | $79,293 | $62,958 |
| Assets | $16,381,851 | $18,222,715 | $19,620,780 | $19,819,771 |
| Long-term Debt, Excluding Current Maturities | $6,135,285 | $6,614,653 | $8,570,917 | $8,581,892 |
| Accounts Payable and Accrued Liabilities, Noncurrent | — | — | $577,870 | $713,219 |
| Other Liabilities, Noncurrent | $900 | $12,080 | $120,843 | $108,018 |
| Liabilities | $6,297,562 | $7,880,349 | $9,905,841 | $10,034,057 |
| Cash and Cash Equivalents, at Carrying Value | $477,010 | $929,026 | $618,696 | $811,986 |
| Financing Receivable, after Allowance for Credit Loss, Current | $738,438 | $783,770 | $854,386 | $889,454 |
| Debt Securities, Available-for-sale, Current | $18,300 | $58,200 | $18,800 | $25,000 |
| Other Assets, Current | $3,798 | $4,187 | $6,893 | $6,656 |
| Assets, Current | $1,274,193 | $1,802,139 | $1,528,091 | $1,764,570 |
| Accounts Payable and Accrued Liabilities, Current | $15,165 | $13,370 | $19,404 | $35,566 |
| Interest Payable, Current | $51,682 | $98,062 | $110,818 | $107,766 |
| Long-term Debt, Current Maturities | $0 | $997,773 | $380,000 | $380,000 |
| Other Liabilities, Current | $11,375 | $68,600 | $53,164 | $16,316 |
| Liabilities, Current | $161,377 | $1,253,616 | $636,211 | $630,928 |
| Additional Paid in Capital | $4,011,435 | $4,103,482 | $4,123,088 | $4,376,266 |
| Retained Earnings (Accumulated Deficit) | $2,517,583 | $2,845,653 | $2,356,318 | $2,459,089 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $3,557,792 | $3,395,785 | $3,238,039 | $2,952,975 |
| Treasury Stock, Common, Value | — | — | $2,612 | $2,724 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $10,084,289 | $10,342,366 | $9,714,939 | $9,785,714 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Proceeds from Equity Method Investment, Distribution | $18,823 | $13,396 | $13,396 | $24,738 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-1,233,741 | $452,016 | $-310,330 | $180,078 |
| Proceeds from Interest Received | $71,604 | $46,482 | $34,308 | $25,095 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $477,010 | $929,026 | $618,696 | $117,371 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $169,168 | $159,570 | $276,291 | $315,545 |
| Net Cash Provided by (Used in) Operating Activities | $2,987,802 | $2,768,986 | $2,489,823 | $2,976,457 |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | $74,416 | $226 |
| Proceeds from Equity Method Investment, Distribution, Return of Capital | $43,882 | $23,641 | $105,149 | $34,991 |
| Payments to Acquire Equity Method Investments | $12,542 | $10,955 | $0 | $0 |
| Payments to Acquire Debt Securities, Available-for-sale | $0 | $150,000 | $175,000 | $100,000 |
| Proceeds from Sale of Debt Securities, Available-for-sale | $1,440 | $19,786 | $21,226 | $14,400 |
| Proceeds from Sale and Maturity of Marketable Securities | $24,391 | $0 | $0 | $0 |
| Payments to Acquire Finance Receivables | $2,115,522 | $2,505,701 | $1,697,729 | $2,398,945 |
| Payments to Acquire Other Investments | $0 | $18,000 | $0 | $0 |
| Payments for (Proceeds from) Other Investing Activities | $2,038 | $-2,039 | $8,946 | $317 |
| Net Cash Provided by (Used in) Investing Activities | $-2,072,789 | $-2,678,115 | $-1,614,180 | $-2,513,702 |
| Payments to Noncontrolling Interests | $119,534 | $125,159 | $167,475 | $149,512 |
| Payments for Repurchase of Common Stock | $304,759 | $229,651 | $1,227,383 | $321,773 |
| Proceeds from Long-term Lines of Credit | $350,000 | $0 | $1,275,000 | $1,275,000 |
| Repayments of Lines of Credit | — | — | $1,275,000 | $1,275,000 |
| Repayments of Other Long-term Debt | $1,000,000 | $0 | $1,000,000 | $1,000,000 |
| Proceeds from Issuance of Other Long-term Debt | $0 | $1,471,235 | $1,954,475 | $1,954,475 |
| Payments of Debt Issuance Costs | $1,596 | $12,616 | $16,563 | $19,021 |
| Proceeds from (Payments for) Other Financing Activities | — | $-9,026 | $-1,790 | $-2,405 |
| Net Cash Provided by (Used in) Financing Activities | $-2,148,754 | $361,145 | $-1,185,973 | $-282,677 |
| Financing Receivable, Allowance for Credit Loss | $3,065,145 | $3,789,281 | $3,397,481 | $2,456,559 |
| Financing Receivable, Credit Loss, Expense (Reversal) | $22,285 | $100,415 | $26,163 | $3,835 |